NDC 58368-012

Veive CBD Muscle Relaxer

Arnica Montana, Causticum, Rhamnus Californica, Ruta Graveolens, Taraxacum Officinale, Belladonna, Cimicifuga Racemosa, Gnaphalium Polycephalum, Hypericum Perforatum, Jatropha Curcas, Veratrum Album, Cina, Ignatia Amara, Kali Bromatum, Kali Carbonicum, Lycopodium Clavatum, Scutellaria Lateriflora, Valeriana Officinalis

Veive CBD Muscle Relaxer is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Biolyte Laboratories, Llc. The primary component is Arnica Montana; Strychnos Ignatii Seed; Ruta Graveolens Flowering Top; Scutellaria Lateriflora Whole; Taraxacum Officinale; Valerian; Veratrum Album Root; Atropa Belladonna; Causticum; Artemisia Cina Flower; Potassium Bromide; Potassium Carbonate; Frangula Californica Bark; Hypericum Perforatum; Lycopodium Clavatum Spore; Black Cohosh; Pseudognaphalium Obtusifolium; Jatropha Curcas Seed.

• Product ID: 58368-012_b3b28d17-d10a-2f5c-e053-2995a90a323a
• NDC: 58368-012
• Product Type: Human Otc Drug
• Proprietary Name: Veive CBD Muscle Relaxer
• Generic Name: Arnica Montana, Causticum, Rhamnus Californica, Ruta Graveolens, Taraxacum Officinale, Belladonna, Cimicifuga Racemosa, Gnaphalium Polycephalum, Hypericum Perforatum, Jatropha Curcas, Veratrum Album, Cina, Ignatia Amara, Kali Bromatum, Kali Carbonicum, Lycopodium Clavatum, Scutellaria Lateriflora, Valeriana Officinalis
• Dosage Form: Cream
• Route of Administration: TOPICAL
• Marketing Start Date: 2020-11-16
• Marketing Category: UNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
• Labeler Name: BioLyte Laboratories, LLC
• Substance Name: ARNICA MONTANA; STRYCHNOS IGNATII SEED; RUTA GRAVEOLENS FLOWERING TOP; SCUTELLARIA LATERIFLORA WHOLE; TARAXACUM OFFICINALE; VALERIAN; VERATRUM ALBUM ROOT; ATROPA BELLADONNA; CAUSTICUM; ARTEMISIA CINA FLOWER; POTASSIUM BROMIDE; POTASSIUM CARBONATE; FRANGULA CALIFORNICA BARK; HYPERICUM PERFORATUM; LYCOPODIUM CLAVATUM SPORE; BLACK COHOSH; PSEUDOGNAPHALIUM OBTUSIFOLIUM; JATROPHA CURCAS SEED
• Active Ingredient Strength: 4 [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 58368-012-01

5 g in 1 PACKET (58368-012-01)

• Marketing Start Date: 2020-11-16
• NDC Exclude Flag: N
• Sample Package?: Y

Drug Details